Fordham University law professor Deborah Denno said in an interview that because many of the drugs used for executions are manufactured in European countries that oppose the death penalty, there has been a reluctance to sell to states for that purpose. Even U.S. pharmaceutical companies don't want their drugs to be associated with executions, she said.

Source: Los Angeles Times May 09, 2018 02:48 UTC